Glucagon-like peptide-1 receptor agonists (GLP-1RAs), originally developed for treating diabetes, work by stimulating insulin secretion and suppressing glucagon release, thereby helping regulate blood ...

Amphastar Pharmaceuticals has a growth model based on organic growth and acquisitions, though competition and patent ...

Citius Pharma’s late-stage pipeline also includes Mino-Lok, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections, and CITI-002, a topical ...

Glucagon-like peptide receptor agonists (GLP-1RAs ... However, she notes that addiction treatment is unlikely to be a one-size-fits-all approach. Some formulations may work better for certain ...

With today’s sweetener market evolving rapidly, experts highlight how natural sweetener solutions are helping beverage-makers ...

“There was a demand for clean, natural, and effective formulations, products that not only nourish hair but are also safe for the planet. That’s what inspired me to create a solution that ...

After hours: February 20 at 5:47:05 PM EST ...

It encompasses drug formulation and manufacturing. Repurposed drugs provide a rich source of potential therapies for Alzheimer’s disease (AD) and other neurodegenerative disorders (NDD).